The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Research Using Biosamples and Subjects from Type 1 Diabetes Clinical Studies –Complications (DP3)
This Funding Opportunity Announcement (FOA) invites applications for studies on the complications of type 1 diabetes using subjects and/or samples from clinical studies on type 1 diabetes.
- Letter of Intent Due Date: Feb. 3, 2016
- Application Due Date(s): Mar. 3, 2016, by 5:00 PM local time of applicant organization.
RFA-DK-15-019 Expiration Date March 4, 2016
The maximum direct costs are $1 million for the entire project period. Facilities and Administrative (F&A) costs to be determined at the time of award. F&A costs requested by consortium participants are not included in the direct cost limitation.
The scope of the proposed project should determine the project period. The maximum project period is 3 years.